Number of eligible individuals: CDEC mentioned the uncertainty in the amount of individuals with moderately serious to extreme hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical experts consulted by CADTH indicated that some patients who will be labeled as owning delicate or reasonable condition might have a serious bleeding ph… Read More